Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 84

1.

Novel mutations and expression alterations in SMAD3/TGFBR2 genes in oral carcinoma correlate with poor prognosis.

Sivadas VP, George NA, Kattoor J, Kannan S.

Genes Chromosomes Cancer. 2013 Nov;52(11):1042-52. doi: 10.1002/gcc.22099. Epub 2013 Aug 3.

PMID:
23913824
2.

The early manifestation, tumor-specific occurrence and prognostic significance of TGFBR2 aberrant splicing in oral carcinoma.

Sivadas VP, Gulati S, Varghese BT, Balan A, Kannan S.

Exp Cell Res. 2014 Sep 10;327(1):156-62. doi: 10.1016/j.yexcr.2014.05.004. Epub 2014 May 15.

PMID:
24846200
3.

Downregulation of TGF-beta receptor types II and III in oral squamous cell carcinoma and oral carcinoma-associated fibroblasts.

Meng W, Xia Q, Wu L, Chen S, He X, Zhang L, Gao Q, Zhou H.

BMC Cancer. 2011 Feb 28;11:88. doi: 10.1186/1471-2407-11-88.

4.

Changes in expression, and/or mutations in TGF-beta receptors (TGF-beta RI and TGF-beta RII) and Smad 4 in human ovarian tumors.

Antony ML, Nair R, Sebastian P, Karunagaran D.

J Cancer Res Clin Oncol. 2010 Mar;136(3):351-61. doi: 10.1007/s00432-009-0703-4.

PMID:
19916025
5.

Novel TGFBR2 and known missense SMAD3 mutations: two case reports of thoracic aortic aneurysms.

Panesi P, Foffa I, Sabina S, Ait Ali L, Andreassi MG.

Ann Thorac Surg. 2015 Jan;99(1):303-5. doi: 10.1016/j.athoracsur.2014.02.068.

PMID:
25555948
6.

Genetic alterations of the transforming growth factor beta receptor genes in pancreatic and biliary adenocarcinomas.

Goggins M, Shekher M, Turnacioglu K, Yeo CJ, Hruban RH, Kern SE.

Cancer Res. 1998 Dec 1;58(23):5329-32.

8.

Involvement of TSC genes and differential expression of other members of the mTOR signaling pathway in oral squamous cell carcinoma.

Chakraborty S, Mohiyuddin SM, Gopinath KS, Kumar A.

BMC Cancer. 2008 Jun 6;8:163. doi: 10.1186/1471-2407-8-163.

10.
11.

miR-135b Promotes Cancer Progression by Targeting Transforming Growth Factor Beta Receptor II (TGFBR2) in Colorectal Cancer.

Li J, Liang H, Bai M, Ning T, Wang C, Fan Q, Wang Y, Fu Z, Wang N, Liu R, Zen K, Zhang CY, Chen X, Ba Y.

PLoS One. 2015 Jun 10;10(6):e0130194. doi: 10.1371/journal.pone.0130194. eCollection 2015. Erratum in: PLoS One. 2015;10(12):e0145589.

12.

TGFB1 and TGFBR2 functional polymorphisms and risk of esophageal squamous cell carcinoma: a case-control analysis in a Chinese population.

Jin G, Deng Y, Miao R, Hu Z, Zhou Y, Tan Y, Wang J, Hua Z, Ding W, Wang L, Chen W, Shen J, Wang X, Xu Y, Shen H.

J Cancer Res Clin Oncol. 2008 Mar;134(3):345-51. Epub 2007 Aug 7.

PMID:
17680270
13.

Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.

Su L, Wang Y, Xiao M, Lin Y, Yu L.

Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2010 Oct;110(4):484-91. doi: 10.1016/j.tripleo.2010.04.009.

PMID:
20868995
14.

Analysis of specific gene mutations in the transforming growth factor-beta signal transduction pathway in human ovarian cancer.

Wang D, Kanuma T, Mizunuma H, Takama F, Ibuki Y, Wake N, Mogi A, Shitara Y, Takenoshita S.

Cancer Res. 2000 Aug 15;60(16):4507-12.

15.

Downregulation of miR-145 expression in oral squamous cell carcinomas and its clinical significance.

Gao L, Ren W, Chang S, Guo B, Huang S, Li M, Guo Y, Li Z, Song T, Zhi K, Huang C.

Onkologie. 2013;36(4):194-9. doi: 10.1159/000349956. Epub 2013 Mar 18.

PMID:
23548968
16.

Concordant repression and aberrant methylation of transforming growth factor-beta signaling pathway genes occurs early in gastric cardia adenocarcinoma.

Guo W, Dong Z, Guo Y, Kuang G, Yang Z, Shan B.

Mol Biol Rep. 2012 Oct;39(10):9453-62. doi: 10.1007/s11033-012-1810-x. Epub 2012 Jun 22.

PMID:
22722999
17.

PIK3CA mutation is an oncogenic aberration at advanced stages of oral squamous cell carcinoma.

Kozaki K, Imoto I, Pimkhaokham A, Hasegawa S, Tsuda H, Omura K, Inazawa J.

Cancer Sci. 2006 Dec;97(12):1351-8.

18.

Methylation silencing of transforming growth factor-beta receptor type II in rat prostate cancers.

Yamashita S, Takahashi S, McDonell N, Watanabe N, Niwa T, Hosoya K, Tsujino Y, Shirai T, Ushijima T.

Cancer Res. 2008 Apr 1;68(7):2112-21. doi: 10.1158/0008-5472.CAN-07-5282.

19.

Expression of apoptosis-regulating miRNAs and target mRNAs in oral squamous cell carcinoma.

Coutinho-Camillo CM, Lourenço SV, de Araújo Lima L, Kowalski LP, Soares FA.

Cancer Genet. 2015 Jul-Aug;208(7-8):382-9. doi: 10.1016/j.cancergen.2015.04.004. Epub 2015 Apr 17.

PMID:
26027785
20.

Mutation analysis of transforming growth factor beta type II receptor, Smad2, Smad3 and Smad4 in esophageal squamous cell carcinoma.

Osawa H, Shitara Y, Shoji H, Mogi A, Kuwano H, Hagiwara K, Takenoshita S.

Int J Oncol. 2000 Oct;17(4):723-8.

PMID:
10995883

Supplemental Content

Support Center